Shafique Virani, Chief Officer of Recursion Pharmaceuticals RXRX, has filed 0 purchases and 17 sales on the open market. The latest trade was on 24/01/16.

SV

SV

Shafique Virani

Chief Business Officer

Company

Recursion Pharmaceuticals RXRX

First filing

23/01/19

Trades

53 trades

Buys / sales

0 / 17

12-month net buying

No record

Last trade

24/01/16

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	24/01/16	24/01/18	18,000 sh	$10.93	$196,740	−11.6%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	23/12/15	23/12/19	18,000 sh	$9.60	$172,800	−11.6%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	23/11/15	23/11/17	18,000 sh	$6.51	$117,180	−11.4%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	23/10/16	23/10/18	18,000 sh	$6.30	$113,400	−11.4%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	23/09/15	23/09/19	18,000 sh	$8.66	$155,880	−11.4%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	23/08/15	23/08/17	18,000 sh	$9.25	$166,500	−11.4%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	23/07/25–23/07/26	23/07/27	40,000 sh2 trades	$14.36avg.	$574,200	−21.7%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	23/07/17–23/07/18	23/07/19	60,000 sh2 trades	$12.73avg.	$763,800	−29.4%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	23/06/15–23/06/16	23/06/20	60,000 sh2 trades	$9.54avg.	$572,400	−29.4%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	23/06/01–23/06/02	23/06/05	42,865 sh2 trades	$8.73avg.	$374,034.45	−22.9%
Recursion PharmaceuticalsRXRX	Open-market sale	23/02/15–23/02/16	23/02/17	9,254 sh2 trades	$8.35avg.	$77,244.94	−4.7%
Recursion PharmaceuticalsRXRX	Open-market sale	23/01/17	23/01/19	10,000 sh	$9.16	$91,600	−12.0%